it is argued that the canadian stroke study showed that aspirin protects men with transient ischemic attacks from coronary death as well as from stroke , that type ii errors may have been made in some clinical trials , that aspirin protects women as well as men , that aspirin benefits patients who have had a heart attack , that the effect of aspirin in angina varies with the type of angina , that the dose of aspirin used may not be critical , that guidelines for use of dipyridamole and sulfinpyrazone are still inconclusive , and that exercise and fish oil supplements may be `` '' antithrombotic . '' ''
C0002962
angina
C0038742
sulfinpyrazone